Concepedia

Fu Li

FL

Statistics

Publications

2

Citations

123

H-Index

2

Active since

1996

Affiliations

Apellis Pharmaceuticals (United States)(Current)

Fu Li is an author at Apellis Pharmaceuticals (United States) specializing in oncology, safety profile characterization, and antibody-drug conjugate therapy.

ORCID

Publications per year

1996–2023

2

Publications

2

Treatment of small cell lung carcinoma in the elderly

Esther Dajczman, Fu Li, David H. Small et al. · Cancer · 1996 · 84 citations · Full text

, , +10

Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody–Drug Conjugate for the Treatment of Cancer

Dorin Toader, Shawn P. Fessler, Scott D. Collins et al. · Molecular Cancer Therapeutics · 2023 · 39 citations · Full text

, , +17

1–2 of 2